Support & Resources

Connect With Us

To learn more about VYJUVEK, complete this form or call 1-844-5-KRYSTAL

*Required fields
If you are under 18 years old, a parent or guardian should fill out this form.

Which best describes you?

I am a person living with dystrophic epidermolysis bullosa (DEB)I am a caregiver and/or a loved one of someone living with DEBI think I may have DEBI think someone I care for and/or a loved one may have DEB

First Name

Last Name

Email

Phone

ZIP Code

DEB Healthcare Professional First Name

DEB Healthcare Professional Last Name

DEB Healthcare Professional State

Check to indicate you are 18 years of age or olderCheck if it is NOT okay to leave a voicemail

Consent

I authorize Krystal Biotech, Inc. (“Krystal”), and companies working with Krystal, to contact me including by mail, email, fax, telephone call, and text message (including autodialed and prerecorded calls and messages) to provide me with information about Krystal products, services, and programs or other topics of interest, conduct market research, or otherwise ask me about my experience with or thoughts about such topics. I understand and agree that any information that I provide may be used by Krystal to help develop new products, services, and programs. I note that Krystal will not sell or transfer my personal data to any unrelated third party for marketing purposes without my express permission. I understand that my consent is not required as a condition of purchasing or receiving any goods or services from Krystal. I understand that I may revoke this authorization and choose not to receive information or further contact from Krystal by clicking the unsubscribe link in future Krystal communications or by visiting KrystalBio.com/privacy.

I agree to Privacy Policy and Marketing Authorization as described above.

INDICATION AND USAGE

VYJUVEK is a topical gel used to treat wounds in patients 6 months and older with dystrophic epidermolysis bullosa (DEB).

IMPORTANT SAFETY INFORMATION

VYJUVEK gel must be applied by a healthcare provider.

After treatment, patients and caregivers should be careful not to touch treated wounds and dressings for 24 hours. If accidentally exposed to the VYJUVEK gel, clean the affected area.

Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from the first dressing change with a virucidal agent, and dispose of the disinfected bandages in a separate sealed plastic bag in household waste. Dispose of the subsequent used dressings in a sealed plastic bag in household waste.

Patients should avoid touching or scratching wound sites or wound dressings.

The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose. These are not all the possible side effects with VYJUVEK. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or to the Sponsor at 1-844-557-9782.

Please see Important Safety Information above and click here for full Prescribing Information.

IMPORTANT SAFETY INFORMATION

INDICATION AND USAGE

VYJUVEK is a topical gel used to treat wounds in patients 6 months and older with dystrophic epidermolysis bullosa (DEB).

IMPORTANT SAFETY INFORMATION

VYJUVEK gel must be applied by a healthcare provider.

After treatment, patients and caregivers should be careful not to touch treated wounds and dressings for 24 hours. If accidentally exposed to the VYJUVEK gel, clean the affected area.

Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from the first dressing change with a virucidal agent, and dispose of the disinfected bandages in a separate sealed plastic bag in household waste. Dispose of the subsequent used dressings in a sealed plastic bag in household waste.

Patients should avoid touching or scratching wound sites or wound dressings.

The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose. These are not all the possible side effects with VYJUVEK. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or to the Sponsor at 1-844-557-9782.

Please see Important Safety Information above and click here for full Prescribing Information.